Clearstead Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,228
Closed -$55.6K 2675
2025
Q4
$55.6K Buy
1,228
+1,218
+12,180% +$44.6K ﹤0.01% 1361
2025
Q3
$305 Buy
+10
New +$307 ﹤0.01% 2803
2025
Q1
Sell
-70
Closed -$3.12K 2284
2024
Q4
$3.12K Buy
+70
New +$3.14K ﹤0.01% 1786
2024
Q3
Sell
-259
Closed -$7.01K 2092
2024
Q2
$7.01K Buy
+259
New +$7.5K ﹤0.01% 1619

Other funds holding OMCL

Clearstead Advisors's OMCL Position: Q1 2026 in Review

Clearstead Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 1,228 shares — an estimated $55.6K sold.

Clearstead Advisors first reported a position in OMCL in Q2 2024 and held it in 4 quarters. The position peaked at $55.6K in Q4 2025. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Clearstead Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 1,228 Omnicell shares in Q1 2026, an estimated $55.6K.
  • Clearstead Advisors first reported a position in Omnicell in Q2 2024 and held it in 4 quarters.
  • Clearstead Advisors's Omnicell position peaked at $55.6K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.